Showing results (311-320 of 492) with videos related to

Sort By:
Pageof 50
Cell Death & Disease|April 4, 2026
Therapeutic potential of BH3-mimetics and NK cell-mediated immunotherapy in T-ALLColin Fortner, Alexandra Niedermayer, Melina Maria Bäuerle, et al.
Haematologica|March 10, 2018
Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic stateLuca Trentin, Manon Queudeville, Sarah Mirjam Eckhoff, et al.
Biological Chemistry|June 21, 2018
Selective BH3-mimetics targeting BCL-2, BCL-XL or MCL-1 induce severe mitochondrial perturbationsKristina Henz, Aoula Al-Zebeeby, Marion Basoglu, et al.
Biochemical Pharmacology|July 29, 2014
The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancerSimone Braig, Fabian Bischoff, Behnaz A Abhari, et al.
Cell Death & Disease|February 17, 2019
Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stressBehnaz Ahangarian Abhari, Nicole McCarthy, Marie Le Berre, et al.
Biochemical Pharmacology|December 25, 2010
NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapyIsabelle Coupienne, Sébastien Bontems, Michael Dewaele, et al.
Blood|May 24, 2014
Smac mimetic and glucocorticoids synergize to induce apoptosis in childhood ALL by promoting ripoptosome assemblyKatharina Belz, Hannah Schoeneberger, Sibylle Wehner, et al.
Cell Death & Disease|September 26, 2020
Correction: Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stressBehnaz Ahangarian Abhari, Nicole McCarthy, Marie Le Berre, et al.
Neoplasia (New York, N.Y.)|December 7, 2018
Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer CellsAnne-Kathrin Knuth, Stefanie Rösler, Barbara Schenk, et al.
Pageof 50